Aerovate Therapeutics Inc (AVTE) Financials

$2.68

up-down-arrow $-91.12 (-97.14%)

As on 28-Apr-2025 16:28EDT

Market cap

info icon

$78 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

35.6

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Operating Revenue
--
--
--
--
--
--
Cost of Revenue
0.03
--
0.10
0.07
0.02
0.00
Gross Profit
-0.03
--
-0.10
-0.07
-0.02
0.00
Operating Expenses
53.37
74.60
81.41
53.24
23.02
8.89
Operating Profit (EBIT)
-53.37
-74.60
-81.41
-53.24
-23.02
-8.89
Other Income
--
--
--
--
--
--
Profit before Tax
-48.91
-69.57
-75.47
-51.49
-22.96
-9.61
Provision for Tax
-2.46
0.06
0.06
0.03
0.00
-0.57
Profit after Tax (Net Income)
-48.96
-69.63
-75.52
-51.51
-22.96
-9.04
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
--
--
-22.99
-9.76

Liabilities ($ Mln)

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Shareholder's Funds
75.05
76.43
109.46
126.74
172.42
-13.34
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
0.07
0.07
0.33
0.78
0.40
16.29
Current Liabilities
2.42
3.83
17.64
7.78
2.55
1.77
Total Liabilities
79.95
80.33
127.42
135.30
175.36
4.72

Assets ($ Mln)

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Non-Current Assets
0.16
0.22
3.19
3.81
1.03
0.04
Current Assets
77.37
80.12
124.23
131.50
174.33
4.68
Total Assets
154.91
80.33
127.42
135.30
175.36
4.72
Total Debt*
0.31
0.42
0.68
1.09
0.57
--
Net Current Assets
--
76.29
106.60
123.71
171.78
2.90

Cashflow ($ Mln)

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Cash From Operating Activities
--
-71.20
-56.78
-39.12
-27.40
-7.86
Cash Flow from Investing Activities
--
--
--
--
-113.43
-113.43
Cash from Financing Activities
--
25.43
46.00
0.40
190.46
8.92
Net Cash Inflow / Outflow
--
--
--
--
--
--

Financials Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Adjusted EPS ($) info
--
--
--
--
--
--
Cash EPS ($) info
--
--
--
--
--
--
Adjusted Book Value ($) info
--
--
--
--
--
--
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
--
--
--
--
--
Free Cash Flow per Share ($) info
--
--
--
--
--
--

Profitability Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
ROCE (%) info
--
-74.48
-63.47
-34.25
-28.77
124.79
ROE (%) info
-62.96
-74.91
-63.95
-34.44
-28.87
106.42
ROA (%) info
-35.32
-67.03
-57.49
-33.16
-25.50
-219.69
EBIT Margin (%) info
--
--
--
--
--
--
Net Margin (%) info
--
--
--
--
--
--
Cash Profit Margin (%) info
--
--
--
--
--
--

Growth Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Revenue Growth (%) info
--
--
--
--
--
--
EBIT Growth (%) info
43.46
8.37
-52.92
-131.24
-158.99
-167.02
Net Profit Growth (%) info
40.43
7.80
-46.61
-124.32
-154.04
-171.44
EPS Growth (%) info
--
--
--
--
--
--
Book Value Growth (%) info
--
--
--
--
--
--

Valuation Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Price / Earnings info
--
--
--
--
--
--
Price / Book Value info
35.57
--
--
--
--
--
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
-9.33
1.05
1.50
2.41
7.25
--
Close Price ($) info
87.85
92.75
792.05
1,025.50
412.65
--
High Price ($) info
1,134.53
1,134.53
1,058.40
1,077.65
1,030.05
--
Low Price ($) info
43.75
43.75
329.35
270.90
309.05
--
Market Cap ($ Cr) info
77.68
--
--
--
--
--

Solvency Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Debt to Equity info
--
0.01
0.01
0.01
0.00
--
Short term debt to equity ratio info
0.00
0.01
0.00
0.01
0.00
--
Current Ratio info
32.01
20.93
7.04
16.90
68.37
2.64
Quick Ratio info
32.01
--
--
--
--
--
Interest Coverage info
--
--
--
-30.40
-354.18
-118.52

Operating Efficiency Ratios

TTM Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15
Debtors to sales (%) info
--
--
--
--
--
--
Asset Turnover info
--
--
--
--
--
--
Receivable days info
--
--
--
--
--
--
Inventory Days info
--
--
--
--
--
--
Payable days info
--
--
9,456.55
10,159.86
22,158.50
210,749.25
Cash Conversion Cycle info
--
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...